{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:30:16Z","timestamp":1792791016991,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatric.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Geriatric Medicine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cger.2021.01.003","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T16:14:38Z","timestamp":1616516078000},"page":"289-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cancer and Peripheral Nerve Disease"],"prefix":"10.1016","volume":"37","author":[{"given":"Jonathan","family":"Sarezky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Elinzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Stavros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cger.2021.01.003_bib1","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.cger.2021.01.003_bib2","doi-asserted-by":"crossref","first-page":"e19029","DOI":"10.1097\/MD.0000000000019029","article-title":"Emotional distress and quality of life during folinic acid, fluorouracil, and oxaliplatin in colorectal cancer patients with and without chemotherapy-induced peripheral neuropathy: a cross-sectional study","volume":"99","author":"Hsu","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.cger.2021.01.003_bib3","first-page":"2261","article-title":"Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review","volume":"22","author":"Mols","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.cger.2021.01.003_bib4","first-page":"913848","article-title":"Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer","volume":"2012","author":"Pike","year":"2012","journal-title":"Chemother Res Pract"},{"issue":"6","key":"10.1016\/j.cger.2021.01.003_bib5","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3390\/ijms20061451","article-title":"Mechanisms of chemotherapy-induced peripheral neuropathy","volume":"20","author":"Zajaczkowska","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.cger.2021.01.003_bib6","first-page":"9","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"249","author":"Quasthoff","year":"2002","journal-title":"J\u00a0Neurol"},{"issue":"7","key":"10.1016\/j.cger.2021.01.003_bib7","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1356::AID-CNCR20>3.0.CO;2-#","article-title":"Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A","volume":"77","author":"Graf","year":"1996","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.cger.2021.01.003_bib8","first-page":"1999","article-title":"A\u00a0systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration","volume":"22","author":"Beijers","year":"2014","journal-title":"Support Care Cancer"},{"issue":"30","key":"10.1016\/j.cger.2021.01.003_bib9","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1200\/JCO.2014.58.8533","article-title":"Clinical course of oxaliplatin-induced neuropathy: results from the randomized phase III Trial N08CB (Alliance)","volume":"33","author":"Pachman","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.cger.2021.01.003_bib10","doi-asserted-by":"crossref","first-page":"e00558","DOI":"10.1002\/brb3.558","article-title":"Chemotherapy-induced neuropathies-a growing problem for patients and health care providers","volume":"7","author":"Banach","year":"2017","journal-title":"Brain Behav"},{"issue":"3","key":"10.1016\/j.cger.2021.01.003_bib11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10549-010-1278-0","article-title":"Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy","volume":"125","author":"Hershman","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.cger.2021.01.003_bib12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/WCO.0000000000000391","article-title":"Neurologic complications of immune checkpoint inhibitors","volume":"29","author":"Hottinger","year":"2016","journal-title":"Curr Opin Neurol"},{"issue":"11","key":"10.1016\/j.cger.2021.01.003_bib13","doi-asserted-by":"crossref","first-page":"e1093","DOI":"10.1212\/WNL.0000000000008091","article-title":"Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies","volume":"93","author":"Dubey","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2021.01.003_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/mus.26070","article-title":"Neuromuscular complications of immune checkpoint inhibitor therapy","volume":"58","author":"Kolb","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cger.2021.01.003_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2016.12.001","article-title":"Neurological adverse events associated with immune checkpoint inhibitors: review of the literature","volume":"73","author":"Cuzzubbo","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cger.2021.01.003_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418799864","article-title":"Neurological complications of immune checkpoint inhibitors: what happens when you 'take the brakes off' the immune system","volume":"11","author":"Dalakas","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.cger.2021.01.003_bib17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/B978-0-444-52902-2.00040-0","article-title":"Malignant cell infiltration in the peripheral nervous system","volume":"115","author":"Grisold","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"24","key":"10.1016\/j.cger.2021.01.003_bib18","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1182\/blood-2009-12-258210","article-title":"Neurolymphomatosis: an international primary CNS lymphoma collaborative group report","volume":"115","author":"Grisariu","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cger.2021.01.003_bib19","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3171\/2015.7.FOCUS15209","article-title":"Perineural spread of pelvic malignancies to the lumbosacral plexus and beyond: clinical and imaging patterns","volume":"39","author":"Capek","year":"2015","journal-title":"Neurosurg Focus"},{"issue":"4","key":"10.1016\/j.cger.2021.01.003_bib20","first-page":"778","article-title":"Prostate cancer with perineural spread and dural extension causing bilateral lumbosacral plexopathy: case report","volume":"122","author":"Capek","year":"2015","journal-title":"J\u00a0Neurosurg"},{"issue":"7","key":"10.1016\/j.cger.2021.01.003_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bdj.2010.292","article-title":"Numb chin syndrome: an ominous clinical sign","volume":"208","author":"Ryba","year":"2010","journal-title":"Br Dent J"},{"issue":"8","key":"10.1016\/j.cger.2021.01.003_bib22","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.cger.2021.01.003_bib23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1212\/01.CON.0000464180.89580.88","article-title":"Paraneoplastic disorders.","volume":"21","author":"Lancaster","year":"2015","journal-title":"Continuum (Minneap Minn)"},{"issue":"5","key":"10.1016\/j.cger.2021.01.003_bib24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/WCO.0000000000000475","article-title":"Paraneoplastic neuropathies","volume":"30","author":"Antoine","year":"2017","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"10.1016\/j.cger.2021.01.003_bib25","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1212\/WNL.0000000000004803","article-title":"Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases","volume":"90","author":"Dubey","year":"2018","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.cger.2021.01.003_bib26","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.12998\/wjcc.v8.i12.2566","article-title":"Demyelinating polyneuropathy and lymphoplasmacytic lymphoma coexisting in 36-year-old man: a case report","volume":"8","author":"Rozlucka","year":"2020","journal-title":"World J Clin Cases"},{"issue":"5","key":"10.1016\/j.cger.2021.01.003_bib27","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.mayocp.2017.02.003","article-title":"Monoclonal gammopathy-associated peripheral neuropathy: diagnosis and management","volume":"92","author":"Chaudhry","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.cger.2021.01.003_bib28","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1034\/j.1399-6576.2001.450907.x","article-title":"Iatrogenic painful neuropathic complications of surgery in cancer","volume":"45","author":"Marchettini","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"issue":"10","key":"10.1016\/j.cger.2021.01.003_bib29","first-page":"1185","article-title":"Persistent postmastectomy pain in breast cancer survivors: analysis of clinical, demographic, and psychosocial factors","volume":"14","author":"Belfer","year":"2013","journal-title":"J\u00a0Pain"},{"issue":"1\u20132","key":"10.1016\/j.cger.2021.01.003_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(03)00241-0","article-title":"Neuropathic pain following breast cancer surgery: proposed classification and research update","volume":"104","author":"Jung","year":"2003","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.cger.2021.01.003_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.radonc.2012.10.012","article-title":"Radiation-induced neuropathy in cancer survivors","volume":"105","author":"Delanian","year":"2012","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.cger.2021.01.003_bib32","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.mayocp.2015.05.004","article-title":"Peripheral neuropathy: a practical approach to diagnosis and symptom management","volume":"90","author":"Watson","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cger.2021.01.003_bib33","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1212\/CON.0000000000000519","article-title":"General approach to peripheral nerve disorders","volume":"23","author":"Russell","year":"2017","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.cger.2021.01.003_bib34","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.21309.1","article-title":"Paraneoplastic diseases of the central nervous system","volume":"9","author":"Galli","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.cger.2021.01.003_bib35","doi-asserted-by":"crossref","first-page":"100653","DOI":"10.1016\/j.blre.2020.100653","article-title":"Peripheral neuropathy in hematologic malignancies - Past, present and future","volume":"43","author":"Li","year":"2020","journal-title":"Blood Rev"},{"issue":"4","key":"10.1016\/j.cger.2021.01.003_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11916-006-0032-0","article-title":"Chemotherapy-induced peripheral neuropathy: underreported and underappreciated","volume":"10","author":"Markman","year":"2006","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"10.1016\/j.cger.2021.01.003_bib37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11912-996-0005-9","article-title":"Peripheral neuropathy and cancer","volume":"6","author":"Forman","year":"2004","journal-title":"Curr Oncol Rep"},{"issue":"6","key":"10.1016\/j.cger.2021.01.003_bib38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/jnci\/djz011","article-title":"The national cancer institute clinical trials planning meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy","volume":"111","author":"Dorsey","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.cger.2021.01.003_bib39","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1200\/JOP.2014.001776","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice guideline summary","volume":"10","author":"Hershman","year":"2014","journal-title":"J\u00a0Oncol Pract"},{"issue":"13","key":"10.1016\/j.cger.2021.01.003_bib40","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cger.2021.01.003_bib41","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1212\/CON.0000000000000873","article-title":"Anticancer drugs and the nervous system","volume":"26","author":"Santomasso","year":"2020","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.cger.2021.01.003_bib42","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/B978-0-444-52902-2.00041-2","article-title":"Paraneoplastic neuropathy","volume":"115","author":"Koike","year":"2013","journal-title":"Handb Clin Neurol"}],"container-title":["Clinics in Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069021000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069021000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:56:54Z","timestamp":1760061414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749069021000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0749069021000033"],"URL":"https:\/\/doi.org\/10.1016\/j.cger.2021.01.003","relation":{},"ISSN":["0749-0690"],"issn-type":[{"value":"0749-0690","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer and Peripheral Nerve Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Geriatric Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cger.2021.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}